Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Post Content
Five friends from Raipur found themselves in a life-threatening situation in Nepal when they narrowly…
Moin Khan urges authorities to honour Imran Khan's right to medical care. He also asked…
Bihar faces intensified flood fears as river water levels rise significantly. Persistent rains in Nepal…
John Cena openly acknowledged the animosity that brewed before his WrestleMania 28 clash with The…